Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Stem Cell Educator Therapy · 1 trial · 1 indication
The primary study endpoint will be the occurrence of treatment-related adverse effects. Adverse events that occur during therapy (especially those that necessitate temporary or permanent discontinuation of therapy) and over the 12-month follow-up period will be assessed.
| Arm | Type | Description |
|---|---|---|
| Stem Cell Educator Therapy | EXPERIMENTAL | Patients will have apheresis performed and then have their own blood returned to them with the "educated" lymphocytes |
| Name | Type | Description |
|---|---|---|
| Stem Cell Educator Therapy | BIOLOGICAL | Patients will receive apheresis and then have their own blood returned to them with the "educated" lymphocytes |
Inclusion Criteria: * Adult patients \>/=18 years * Must have a diagnosis of type 1 diabetes mellitus based on the 2015 American Diabetes Association criteria for the Clarification and Diagnosis of diabetes * Must have a blood test confirming the presence of at least one autoantibody to pancreatic ...